Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Effectiveness and Safety of Pegcetacoplan in Patients with C3 Glomerulopathy or Primary Immune Complex Membranoproliferative Glomerulonephritis

    Recruiting

    3 1 1 1
    Investigated Drugs:
    France Germany Italy Spain
  • Study on Long-Term Effects of Iptacopan in Patients with C3 Glomerulopathy or Idiopathic Immune-Complex Membranoproliferative Glomerulonephritis

    Recruiting

    3 1 1
    Investigated Diseases:
    Czechia France Germany Greece Italy The Netherlands +1
  • Study on the Effectiveness and Safety of Pegcetacoplan for Patients with C3 Glomerulopathy or Immune-Complex Membranoproliferative Glomerulonephritis

    Not recruiting

    3 1 1
    Investigated Drugs:
    Austria Germany Italy The Netherlands
  • Study on the Safety and Effectiveness of Pegcetacoplan for Patients with Post-Transplant Recurrence of C3 Glomerulopathy or Immune Complex Membranoproliferative Nephritis

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    Austria Italy The Netherlands
  • Study on the Effectiveness and Safety of Iptacopan for Patients with Complement 3 Glomerulopathy

    Not recruiting

    3 1
    France Germany Greece Italy The Netherlands Slovakia +1
  • Study Comparing Aliskiren and Enalapril for Patients with C3 Glomerulopathy

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Sweden
  • Study on Long-term Safety and Efficacy of Pegcetacoplan for Patients with C3 Glomerulopathy or Immune-Complex Membranoproliferative Glomerulonephritis

    Not recruiting

    3 1 1 1
    Austria Belgium Czechia France Germany Italy +2